These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18979718)

  • 1. Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE.
    Chalmers J; Joshi R; Kengne AP; MacMahon S
    J Hypertens Suppl; 2008 Jun; 26(2):S11-5. PubMed ID: 18979718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
    Patel A; ; MacMahon S; Chalmers J; Neal B; Woodward M; Billot L; Harrap S; Poulter N; Marre M; Cooper M; Glasziou P; Grobbee DE; Hamet P; Heller S; Liu LS; Mancia G; Mogensen CE; Pan CY; Rodgers A; Williams B
    Lancet; 2007 Sep; 370(9590):829-40. PubMed ID: 17765963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
    Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
    J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trial of the month. ADVANCE: improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes].
    Scheen AJ; Krzesinski JM
    Rev Med Liege; 2007 Oct; 62(10):639-43. PubMed ID: 18069576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights from ADVANCE.
    Chalmers J; Kengne AP; Joshi R; Perkovic V; Patel A
    J Hypertens Suppl; 2007 Jun; 25(1):S23-30. PubMed ID: 17579315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADVANCE: breaking new ground in type 2 diabetes.
    Chalmers J; Perkovic V; Joshi R; Patel A
    J Hypertens Suppl; 2006 Aug; 24(5):S22-8. PubMed ID: 16936533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes.
    Perkovic V; Joshi R; Patel A; Bompoint S; Chalmers J;
    Blood Press; 2006; 15(6):340-6. PubMed ID: 17472024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ADVANCE study: objectives, design and current status].
    Chalmers J
    Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.
    Waeber B; de la Sierra A; Ruilope LM
    Am J Cardiovasc Drugs; 2009; 9(5):283-91. PubMed ID: 19791837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
    PROGRESS Collaborative Group
    Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure and glucose control in subjects with diabetes: new analyses from ADVANCE.
    Poulter NR
    J Hypertens Suppl; 2009 May; 27(1):S3-8. PubMed ID: 19483505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in reducing the burden of vascular disease in type 2 diabetes.
    Chalmers J; Joshi R; Patel A
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):434-7. PubMed ID: 18307736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial.
    Ninomiya T; Zoungas S; Neal B; Woodward M; Patel A; Perkovic V; Cass A; Cooper M; Grobbee D; Hamet P; Harrap S; Liu L; Mancia G; Mogensen CE; Poulter N; Rodgers A; Williams B; MacMahon S; Chalmers J;
    J Hypertens; 2010 Jun; 28(6):1141-9. PubMed ID: 20486273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
    Zoungas S; de Galan BE; Ninomiya T; Grobbee D; Hamet P; Heller S; MacMahon S; Marre M; Neal B; Patel A; Woodward M; Chalmers J; ; Cass A; Glasziou P; Harrap S; Lisheng L; Mancia G; Pillai A; Poulter N; Perkovic V; Travert F
    Diabetes Care; 2009 Nov; 32(11):2068-74. PubMed ID: 19651921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial.
    Mourad JJ; Amodeo C; de Champvallins M; Brzozowska-Villatte R; Asmar R;
    J Hypertens; 2017 Jul; 35(7):1481-1495. PubMed ID: 28306636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ADVANCE: a morbidity mortality study of diabetes and hypertension].
    Heim A; Feihl F; Waeber B
    Rev Med Suisse; 2008 Jan; 4(139):28, 30, 32-3. PubMed ID: 18251212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study.
    Mourad JJ; Lameira D; Guillausseau PJ
    Vasc Health Risk Manag; 2008; 4(2):443-51. PubMed ID: 18561520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowering blood pressure reduces renal events in type 2 diabetes.
    de Galan BE; Perkovic V; Ninomiya T; Pillai A; Patel A; Cass A; Neal B; Poulter N; Harrap S; Mogensen CE; Cooper M; Marre M; Williams B; Hamet P; Mancia G; Woodward M; Glasziou P; Grobbee DE; MacMahon S; Chalmers J;
    J Am Soc Nephrol; 2009 Apr; 20(4):883-92. PubMed ID: 19225038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
    Chalmers J; Castaigne A; Morgan T; Chastang C
    J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER.
    Mogensen CE; Viberti G; Halimi S; Ritz E; Ruilope L; Jermendy G; Widimsky J; Sareli P; Taton J; Rull J; Erdogan G; De Leeuw PW; Ribeiro A; Sanchez R; Mechmeche R; Nolan J; Sirotiakova J; Hamani A; Scheen A; Hess B; Luger A; Thomas SM;
    Hypertension; 2003 May; 41(5):1063-71. PubMed ID: 12654706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.